Bottom line
How much do BBH and IBBQ overlap?
59% of their top holdings overlap by weight. 14 securities appear in both funds' top 25, making up 77.7% of BBH's assets and 46.8% of IBBQ's. They share a meaningful core but differ in the rest of the portfolio.
IBBQ holds far more positions (261 vs 25), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings BBH and IBBQ have in common
| Holding | % of BBH | % of IBBQ | Overlap |
|---|---|---|---|
| Amgen Inc | 15.25% | 7.10% | 7.10% |
| Gilead Sciences Inc | 12.79% | 7.39% | 7.39% |
| Vertex Pharmaceuticals Inc | 9.10% | 7.38% | 7.38% |
| Regeneron Pharmaceuticals Inc | 6.21% | 5.08% | 5.08% |
| Revolution Medicines Inc | 5.27% | 2.48% | 2.48% |
| Argenx SE | 4.97% | 1.89% | 1.89% |
| Alnylam Pharmaceuticals Inc | 3.83% | 3.19% | 3.19% |
| Biogen Inc | 3.63% | 2.29% | 2.29% |
| Moderna Inc | 3.36% | 1.48% | 1.48% |
| Illumina Inc | 3.17% | 1.98% | 1.98% |
| United Therapeutics Corp | 2.83% | 1.94% | 1.94% |
| Insmed Inc | 2.67% | 1.83% | 1.83% |
| Incyte Corp | 2.49% | 1.53% | 1.53% |
| Neurocrine Biosciences Inc | 2.08% | 1.26% | 1.26% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in BBH
- Natera Inc — 4.92%
- IQVIA Holdings Inc — 4.31%
- BeOne Medicines Ltd — 2.81%
- BioNTech SE — 1.94%
- Icon Plc — 1.90%
- Bio-Techne Corp — 1.54%
- Charles River Laboratories International Inc — 1.50%
- BioMarin Pharmaceutical Inc — 1.34%
- Qiagen Nv — 1.06%
- Tempus AI Inc — 0.98%
- State Street Global Advisors — 0.06%
Only in IBBQ
- Invesco Private Prime Fund — 14.20%
- Invesco Private Government Fund — 5.48%
- Royalty Pharma PLC — 1.90%
- Roivant Sciences Ltd. — 1.71%
- Viatris Inc. — 1.49%
- Guardant Health, Inc. — 1.35%
- Jazz Pharmaceuticals PLC — 1.16%
- Ascendis Pharma A/S — 1.10%
- Summit Therapeutics Inc. — 1.08%
- Exelixis, Inc. — 1.04%
- BridgeBio Pharma, Inc. — 1.02%
Asset mix
| Asset type | BBH | IBBQ |
|---|---|---|
| Stocks | 100.0% | 99.9% |
| Cash & short-term funds | 0.1% | 19.7% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)
Country mix
| Country | BBH | IBBQ |
|---|---|---|
| US | 87.3% | 103.8% |
| NL | 6.0% | 2.5% |
| CH | 2.8% | 1.2% |
| GB | — | 2.7% |
| DE | 1.9% | 0.9% |
| IE | 1.9% | 1.9% |
| BM | — | 1.7% |
| FR | — | 1.5% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)
Check another pair
FAQ
How much do BBH and IBBQ overlap?
What stocks do BBH and IBBQ have in common?
Should I own both BBH and IBBQ?
Which holds more stocks, BBH or IBBQ?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.